Health
-
Why we are seeking collaboration in the fight against counterfeit pharmaceutical products – CACCP
The Coalition Against Counterfeit Pharmaceutical Products (CACCP) an umbrella body in conjunction with Nigerian Representatives of Overseas Pharmaceutical Manufacturers (NiroPharm)…
Read More » -
Why we donated equipment worth N3 billion to Aminu Kano Teaching Hospital – Coca Cola
As part of efforts to improve maternal outcomes in the country, the Coca Cola company and its partner, Medshare, in…
Read More » -
COVID-19: Sterling Bank, NHEA recognize Nigeria’s Healthcare Champions
Nigeria’s leading commercial bank, Sterling Bank Plc, has given special recognition awards to healthcare providers who played leading roles in…
Read More » -
How Monkeypox is spreading within communities
The management of the Nigeria Centre for Disease Control (NCDC ) has recorded 10 additional Monkeypox cases in the last…
Read More » -
COVID-19 is not gone, it has only slowed down in Nigeria – FG
Minister of Health, Dr. Osagie Ehanire has warned citizens of a potential resurgence of COVID-19 in Nigeria.
Read More » -
Why Nigeria is off the track in achieving SDG2 – UNICEF
Poverty and hunger have been identified as the major factors responsible for the continuous increase in the number of malnourished…
Read More » -
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the…
Read More » -
COVID-19 Pandemic: Sanwo-Olu Commends Airtel Employees for Support
Governor Babajide Sanwo-Olu of Lagos State has commended employees of Airtel Nigeria for donating the sum of N20 million from…
Read More » -
New AstraZeneca COVID-19 vaccine data further support its use as third dose booster
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S…
Read More » -
Omicron: University of Oxford study supports use of COVID-19 Vaccine AstraZeneca
AstraZeneca’s COVID-19 Vaccine (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose…
Read More »